These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34116343)

  • 1. Detection of SARS-CoV-2 IgG antibodies in dried blood spots.
    Turgeon CT; Sanders KA; Granger D; Nett SL; Hilgart H; Matern D; Theel ES
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115425. PubMed ID: 34116343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.
    Meyers E; Heytens S; Formukong A; Vercruysse H; De Sutter A; Geens T; Hofkens K; Janssens H; Nys E; Padalko E; Deschepper E; Cools P
    Microbiol Spectr; 2021 Oct; 9(2):e0017821. PubMed ID: 34549995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.
    Weisser H; Steinhagen K; Höcker R; Borchardt-Lohölter V; Anvari Ö; Kern PM
    Clin Chem Lab Med; 2021 Apr; 59(5):979-985. PubMed ID: 33554537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots.
    Turgeon CT; Sanders KA; Rinaldo P; Granger D; Hilgart H; Matern D; Theel ES
    PLoS One; 2021; 16(5):e0252621. PubMed ID: 34048503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens.
    Moat SJ; Zelek WM; Carne E; Ponsford MJ; Bramhall K; Jones S; El-Shanawany T; Wise MP; Thomas A; George C; Fegan C; Steven R; Webb R; Weeks I; Morgan BP; Jolles S
    Ann Clin Biochem; 2021 Mar; 58(2):123-131. PubMed ID: 33269949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing.
    Sims MD; Podolsky RH; Childers KL; Higgins B; Trueman J; Homayouni R; Voss DR; Berkiw-Scenna N; Keil H; Kennedy RH; Maine GN
    J Immunol Methods; 2023 Feb; 513():113420. PubMed ID: 36596443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity.
    Styer LM; Hoen R; Rock J; Yauney E; Nemeth K; Bievenue R; Parker MM
    Microbiol Spectr; 2021 Sep; 9(1):e0013421. PubMed ID: 34319133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma.
    Itell HL; Weight H; Fish CS; Logue JK; Franko N; Wolf CR; McCulloch DJ; Galloway J; Matsen FA; Chu HY; Overbaugh J
    Microbiol Spectr; 2021 Oct; 9(2):e0129821. PubMed ID: 34668728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Dried Blood Spots to Quantitatively Detect Anti-SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study.
    Ylade M; Aziz AB; Daag JV; Crisostomo MV; Agrupis KA; Maronilla MA; Sye Lim Hong C; Kim HY; Njau I; Lopez MHJ; Deen J; Kim DR; You YA; Kang SSY; Marks F; Tadesse BT
    Am J Trop Med Hyg; 2024 Aug; 111(2):391-395. PubMed ID: 38917817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fully automated dried blood spot sample handling and extraction for serological testing of SARS-CoV-2 antibodies.
    Gaugler S; Sottas PE; Blum K; Luginbühl M
    Drug Test Anal; 2021 Jan; 13(1):223-226. PubMed ID: 33119946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use.
    Nilsson AC; Holm DK; Justesen US; Gorm-Jensen T; Andersen NS; Øvrehus A; Johansen IS; Michelsen J; Sprogøe U; Lillevang ST
    Int J Infect Dis; 2021 Feb; 103():381-388. PubMed ID: 33310021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay.
    Brinc D; Biondi MJ; Li D; Sun H; Capraru C; Smookler D; Zahoor MA; Casey J; Kulasingam V; Feld JJ
    Viruses; 2021 May; 13(6):. PubMed ID: 34067361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies.
    Khan M; Rosadas C; Katsanovskaja K; Weber ID; Shute J; Ijaz S; Marchesin F; McClure E; Elias S; Flower B; Gao H; Quinlan R; Short C; Rosa A; Roustan C; Moshe M; Taylor GP; Elliott P; Cooke GS; Cherepanov P; Parker E; McClure MO; Tedder RS
    Sci Rep; 2022 Feb; 12(1):1885. PubMed ID: 35115570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots.
    Meyers E; Coen A; De Sutter A; Padalko E; Callens S; Vandekerckhove L; Witkowski W; Heytens S; Cools P
    J Clin Virol; 2022 Oct; 155():105270. PubMed ID: 36027822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device.
    MacMullan MA; Chellamuthu P; Mades A; Das S; Turner F; Slepnev VI; Ibrayeva A
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33234589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients.
    Cook AM; Faustini SE; Williams LJ; Cunningham AF; Drayson MT; Shields AM; Kay D; Taylor L; Plant T; Huissoon A; Wallis G; Beck S; Jossi SE; Perez-Toledo M; Newby ML; Allen JD; Crispin M; Harding S; Richter AG
    J Immunol Methods; 2021 Jul; 494():113046. PubMed ID: 33775672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults.
    Ferentinos P; Snape D; Koivula F; Faustini S; Nicholson-Little A; Stacey M; Gifford R; Parsons I; Lamb L; Greeves J; O'Hara J; Cunningham AF; Woods D; Richter A; O'Shea MK
    J Immunol Methods; 2023 Jul; 518():113492. PubMed ID: 37201783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative and quantitative detection of SARS-CoV-2 antibodies from dried blood spots.
    Omosule CL; Conklin J; Seck S; Howell R; Hock KG; Ballman C; Freeman J; Du Toit L; Dubberke E; Farnsworth CW
    Clin Biochem; 2023 Jul; 117():16-22. PubMed ID: 34990593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.